Related Experiment Video
Updated: May 18, 2026
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Thrombosis in VonWillebrand disease
Waqas Qureshi1, Syed Hassan, Vrushali Dabak
1Internal Medicine, Henry Ford Hospital, Detroit, USA.
Thrombosis Research
|September 22, 2012
Summary
This study found that Von Willebrand disease (VWD) significantly reduces the risk of arterial thrombosis, but not venous thrombosis. These findings suggest VWD may offer protection against arterial clots in younger individuals.
Area of Science:
- Hematology
- Cardiovascular Medicine
- Thrombosis Research
Background:
- Von Willebrand disease (VWD) is a bleeding disorder, and its association with thrombosis is not well-established.
- Few case studies exist, and no incidence data on thrombosis in VWD patients have been reported.
- The hypothesis tested was that decreased Von Willebrand factor (VWF) levels protect against arterial and venous thrombosis.
Purpose of the Study:
- To investigate the incidence of arterial and venous thrombosis in patients with VWD.
- To determine if VWD confers a protective effect against thrombotic events.
- To explore potential differences in thrombotic risk between arterial and venous systems in VWD patients.
Main Methods:
- Retrospective cohort study of 198 VWD patients identified from hospital records over 25 years.
- A matched control group without VWD was selected for comparison.
- Multivariate conditional logistic regression and McNemar's Chi-square test were used to analyze primary outcomes (symptomatic arterial and venous thrombosis).
Main Results:
- VWD was an independent protective predictor against arterial thrombosis (OR 0.28, p<0.0001), particularly in coronary artery disease (CAD) and cerebrovascular disease (CVD).
- No significant association was found between VWD and venous thrombosis (p=0.42).
- The majority of VWD patients (86%) had Type 1 VWD.
Conclusions:
- VWD is associated with a reduced incidence of arterial thrombosis in a relatively young population.
- The protective effect against thrombosis was specific to the arterial system, not the venous system.
- This study is the first large observational study providing insights into thrombotic disease in VWD patients, suggesting potential alternative pathways in thrombosis.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...